You have read all your free articles, to continue reading subscribe to read the rest of this content.
Senzime has signed an agreement to acquire 100 percent of the shares in the US company Respiratory Motion, Inc. for an initial consideration of 19 million USD on a cash- and debt-free basis with an additional potential earn-out payment of up to 25 million USD, paid out earliest in 2024.…
An award winning innovative helmet technology, detecting cancer from breath, self-luminous cancer tissue and hospital health monitoring – examples of recent medtech progress in the Nordic region. Sweden: Innovative helmet technology receives the Polhem Prize Three of the founders of MIPS have beAlready a subscriber Login You have read all…
Nanoform and Celanese Corporation have announced plans to explore the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery. The goal is to assess the utility of combining Nanoform’s nanoparticle platform technologies with Celanese’s VitalDose EVA Already a subscriber Login You have read all your free articles,…
The US Patent and Trademark Office (USPTO) published an Issue of Notification of granting the company's patent application for a method with the medical device, which is one of the components in the product candidate SC0806. The notification states that the US patent will be granted and enters inAlready a…
